Ocular Surface Squamous Neoplasia in 200 Patients: A Case-Control Study of Immunosuppression Resulting from Human Immunodeficiency Virus versus Immunocompetency

作者: Saurabh Kamal , Swathi Kaliki , Dilip K. Mishra , Jyoti Batra , Milind N. Naik

DOI: 10.1016/J.OPHTHA.2015.04.027

关键词:

摘要: Purpose To describe and compare the clinical presentation, treatment outcomes, histopathologic features of ocular surface squamous neoplasia (OSSN) based on human immunodeficiency virus (HIV) status. Design Case-control study. Participants A total 200 patients with OSSN, whom 83 (41%) had positive results for HIV were classified as cases 117 (59%) negative controls. Methods Enzyme-linked immunosorbent assay HIV, conjuntival excision biopsy, extended enucleation, orbital exenteration. Main Outcome Measures Clinical features, characteristics. Results The mean age at presentation OSSN in both controls was 40 years (median, years; range, 13–65 years) 38 15–80 years). On comparison versus HIV-positive individuals larger (12 vs. 8 mm; P  = 0.041) tumors, a higher incidence corneal (60% 40%;  = 0.007), scleral (19% 9%; 0.044), (13% 3%; 0.019) invasion need enucleation or exenteration (27% 11%; 0.13), lamellar sclerectomy 8%; 0.29), tumor recurrence after primary (30% 20%; 0.12) compared HIV-negative However, these not statistically significant. Based American Joint Committee Cancer classification, T1 more common 35% controls; 0.0009), T4 4%  = 0.019). None demonstrated systemic metastases died disease during follow-up period 10 months 4 months; Conclusions Ocular is aggressive and thicker tumors corneal, scleral, invasion. These are associated poor prognosis exenteration, both.

参考文章(32)
E. Midena, Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. British Journal of Ophthalmology. ,vol. 84, pp. 268- 272 ,(2000) , 10.1136/BJO.84.3.268
Bennie H. Jeng, Gary N. Holland, Careen Y. Lowder, William F. Deegan, Michael B. Raizman, David M. Meisler, Anterior Segment and External Ocular Disorders Associated with Human Immunodeficiency Virus Disease Survey of Ophthalmology. ,vol. 52, pp. 329- 368 ,(2007) , 10.1016/J.SURVOPHTHAL.2007.04.010
Jerry A. Shields, Surgical Management of Conjunctival Tumors Archives of Ophthalmology. ,vol. 115, pp. 808- 815 ,(1997) , 10.1001/ARCHOPHT.1997.01100150810025
Charles Ateenyi-Agaba, Min Dai, Florence Le Calvez, Edward Katongole-Mbidde, Anouk Smet, Massimo Tommasino, Silvia Franceschi, Pierre Hainaut, Elisabete Weiderpass, TP53 mutations in squamous-cell carcinomas of the conjunctiva: evidence for UV-induced mutagenesis. Mutagenesis. ,vol. 19, pp. 399- 401 ,(2004) , 10.1093/MUTAGE/GEH048
Emmett T. Cunningham, Philippe G. Kestelyn, HIV/AIDS and blindness Bulletin of The World Health Organization. ,vol. 79, pp. 208- 213 ,(2001) , 10.1590/S0042-96862001000300008
Stephen Gichuhi, James H Irlam, Interventions for squamous cell carcinoma of the conjunctiva in HIV‐infected individuals Cochrane Database of Systematic Reviews. ,vol. 18, ,(2013) , 10.1002/14651858.CD005643.PUB3
Jenna Besley, Juanita Pappalardo, Graham A. Lee, Lawrence W. Hirst, Stephen J. Vincent, Risk Factors for Ocular Surface Squamous Neoplasia Recurrence after Treatment With Topical Mitomycin C and Interferon Alpha-2b American Journal of Ophthalmology. ,vol. 157, pp. 287- 293 ,(2014) , 10.1016/J.AJO.2013.10.012
Irma Illyes Makupa, Britta Swai, William Uforo Makupa, Valerie A White, Susan Lewallen, Clinical factors associated with malignancy and HIV status in patients with ocular surface squamous neoplasia at Kilimanjaro Christian Medical Centre, Tanzania British Journal of Ophthalmology. ,vol. 96, pp. 482- 484 ,(2012) , 10.1136/BJOPHTHALMOL-2011-300485
Thanuja G. Pradeep, Suresh Babu Gangasagara, Guruprasad B. Subbaramaiah, Mala B. Suresh, Nagaraju Gangashettappa, Raviprakash Durgappa, Prevalence of undiagnosed HIV infection in patients with ocular surface squamous neoplasia in a tertiary center in Karnataka, South India. Cornea. ,vol. 31, pp. 1282- 1284 ,(2012) , 10.1097/ICO.0B013E3182479AED